Govt okays ₹13K-cr package to boost bulk drugs production

Business Standard|March 22, 2020

Govt okays ₹13K-cr package to boost bulk drugs production
Industry feels India first needs to tap existing capacity before setting up new drugs parks
SOHINI DAS & PTI Mumbai, 21 March

The Union government on Saturday approved a package comprising four schemes with a total outlay of ₹13,760 crore to boost the domestic production of bulk drugs and medical devices and exports.

The Union Cabinet chaired by Prime Minister Narendra Modi approved outlay of ₹9,940 crore and ₹3,820 crore for bulk drugs and medical devices, respectively, Minister of State for Chemicals and Fertilizers Mansukh Mandaviya told reporters.

The Cabinet also approved a sum of ₹3,000 crore for the next five years for a scheme to promote bulk drug parks and for financing common infrastructure facilities at three such parks, he added.

A sum of ₹6,940 crore has been approved for the Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical key starting material (KSM), drug Intermediates and active pharmaceutical ingredients (APIs), Mandaviya said. The PLI scheme will lead to expected incremental sales of ₹46,400 crore and significant additional employment generation over eight years, he added.

articleRead

You can read up to 3 premium stories before you subscribe to Magzter GOLD

Log in, if you are already a subscriber

GoldLogo

Get unlimited access to thousands of curated premium stories and 5,000+ magazines

READ THE ENTIRE ISSUE

March 22, 2020